Drugs and Devices

FDA approves new treatment for advanced soft tissue sarcoma

On Oct. 19, the Food and Drug Administration (FDA) approved Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares